PUBMED FOR HANDHELDS

Journal Abstract Search


160 related items for PubMed ID: 1860266

  • 1. Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: minimal-change disease and focal-segmental glomerulosclerosis. Collaborative Group of the French Society of Nephrology.
    Meyrier A, Condamin MC, Broneer D.
    Clin Nephrol; 1991; 35 Suppl 1():S37-42. PubMed ID: 1860266
    [Abstract] [Full Text] [Related]

  • 2. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
    Lee HY, Kim HS, Kang CM, Kim SG, Kim MJ.
    Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
    [Abstract] [Full Text] [Related]

  • 3. Safety and tolerability of cyclosporin A (Sandimmun) in idiopathic nephrotic syndrome. Collaborative Study Group of Sandimmun in Nephrotic Syndrome.
    Clin Nephrol; 1991 Jun; 35 Suppl 1():S48-60. PubMed ID: 1860268
    [Abstract] [Full Text] [Related]

  • 4. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Société de Néphrologie.
    Meyrier A, Noël LH, Auriche P, Callard P.
    Kidney Int; 1994 May; 45(5):1446-56. PubMed ID: 8072258
    [Abstract] [Full Text] [Related]

  • 5. Treatment of corticoresistant idiopathic nephrotic syndrome in the adult: minimal change disease and focal segmental glomerulosclerosis.
    Meyrier A, Simon P.
    Adv Nephrol Necker Hosp; 1988 May; 17():127-50. PubMed ID: 3124536
    [Abstract] [Full Text] [Related]

  • 6. Treatment of idiopathic nephrotic syndrome with cyclosporin A in children.
    Niaudet P, Broyer M, Habib R.
    Clin Nephrol; 1991 May; 35 Suppl 1():S31-6. PubMed ID: 1860265
    [Abstract] [Full Text] [Related]

  • 7. Minimal change disease and idiopathic focal segmental glomerulosclerosis in adults. A quantitative study.
    Danilewicz M, Wagrowska-Danilewicz M.
    Pol J Pathol; 1996 May; 47(4):209-14. PubMed ID: 9097714
    [Abstract] [Full Text] [Related]

  • 8. Cyclosporine in idiopathic nephrotic syndrome.
    Ponticelli C.
    Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):479-89. PubMed ID: 8227973
    [Abstract] [Full Text] [Related]

  • 9. Cyclosporin A treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
    Brodehl J, Brandis M, Helmchen U, Hoyer PF, Burghard R, Ehrich JH, Zimmerhackl RB, Klein W, Wonigeit K.
    Klin Wochenschr; 1988 Nov 15; 66(22):1126-37. PubMed ID: 3236762
    [Abstract] [Full Text] [Related]

  • 10. Comparison between pre- and posttreatment renal biopsies in children receiving ciclosporine for idiopathic nephrosis.
    Habib R, Niaudet P.
    Clin Nephrol; 1994 Sep 15; 42(3):141-6. PubMed ID: 7994931
    [Abstract] [Full Text] [Related]

  • 11. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults.
    Maher ER, Sweny P, Chappel M, Varghese Z, Moorhead JF.
    Nephrol Dial Transplant; 1988 Sep 15; 3(6):728-32. PubMed ID: 3147413
    [Abstract] [Full Text] [Related]

  • 12. Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis.
    Ittel TH, Clasen W, Fuhs M, Kindler J, Mihatsch MJ, Sieberth HG.
    Clin Nephrol; 1995 Sep 15; 44(3):156-62. PubMed ID: 8556831
    [Abstract] [Full Text] [Related]

  • 13. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
    Peters HP, van de Kar NC, Wetzels JF.
    Neth J Med; 2008 Nov 15; 66(10):408-15. PubMed ID: 19011266
    [Abstract] [Full Text] [Related]

  • 14. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A, Hill GS, Montseny JJ, Meyrier A.
    Am J Kidney Dis; 2003 Jan 15; 41(1):38-48. PubMed ID: 12500220
    [Abstract] [Full Text] [Related]

  • 15. Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood.
    Woroniecki RP, Shatat IF, Supe K, Du Z, Kaskel FJ.
    Am J Nephrol; 2008 Jan 15; 28(1):83-90. PubMed ID: 17914249
    [Abstract] [Full Text] [Related]

  • 16. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov 15; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 17. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
    Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J.
    Nephrol Dial Transplant; 2007 Aug 15; 22(8):2183-93. PubMed ID: 17504846
    [Abstract] [Full Text] [Related]

  • 18. Cyclosporin therapy for steroid resistant nephrotic focal glomerulosclerosis.
    Windom HH, Fisher M, Neale TJ.
    N Z Med J; 1990 Mar 28; 103(886):125-6. PubMed ID: 2320338
    [Abstract] [Full Text] [Related]

  • 19. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.
    Mahmoud I, Basuni F, Sabry A, El-Husseini A, Hassan N, Ahmad NS, Elbaz M, Moustafa F, Sobh M.
    Nephrol Dial Transplant; 2005 Apr 28; 20(4):735-42. PubMed ID: 15772265
    [Abstract] [Full Text] [Related]

  • 20. The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study.
    Banfi G, Moriggi M, Sabadini E, Fellin G, D'Amico G, Ponticelli C.
    Clin Nephrol; 1991 Aug 28; 36(2):53-9. PubMed ID: 1934660
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.